|
1
|
Nirgianakis K, Kalaitzopoulos DR, Schwartz
ASK, Spaanderman M, Kramer BW, Mueller MD and Mueller M: Fertility,
pregnancy and neonatal outcomes of patients with adenomyosis: A
systematic review and meta-analysis. Reprod Biomed Online.
42:185–206. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Upson K and Missmer SA: Epidemiology of
Adenomyosis. Semin Reprod Med. 38:89–107. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lacheta J: Uterine adenomyosis:
Pathogenesis, diagnostics, symptomatology and treatment. Ceska
Gynekol. 84:240–246. 2019.PubMed/NCBI
|
|
4
|
Che X, Wang J, He J, Yu Q, Sun W, Chen S,
Zou G, Li T, Guo X and Zhang X: A new trick for an old dog: The
application of mifepristone in the treatment of adenomyosis. J Cell
Mol Med. 24:1724–1737. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gunther R and Walker C: Adenomyosis.
StatPearls, Treasure Island, FL, 2022.
|
|
6
|
Li J, Yanyan M, Mu L, Chen X and Zheng W:
The expression of Bcl-2 in adenomyosis and its effect on
proliferation, migration, and apoptosis of endometrial stromal
cells. Pathol Res Pract. 215(152477)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu W, Song Y, Li K, Zhang B and Zhu X:
Quercetin inhibits adenomyosis by attenuating cell proliferation,
migration and invasion of ectopic endometrial stromal cells. Drug
Des Devel Ther. 14:3815–3826. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Harmsen MJ, Wong CFC, Mijatovic V,
Griffioen AW, Groenman F, Hehenkamp WJK and Huirne JAF: Role of
angiogenesis in adenomyosis-associated abnormal uterine bleeding
and subfertility: A systematic review. Hum Reprod Update.
25:647–671. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bourdon M, Santulli P, Jeljeli M,
Vannuccini S, Marcellin L, Doridot L, Petraglia F, Batteux F and
Chapron C: Immunological changes associated with adenomyosis: A
systematic review. Hum Reprod Update. 27:108–129. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
An M, Li D, Yuan M, Li Q, Zhang L and Wang
G: Interaction of macrophages and endometrial cells induces
epithelial-mesenchymal transition-like processes in adenomyosis.
Biol Reprod. 96:46–57. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rier SE, Zarmakoupis PN, Hu X and Becker
JL: Dysregulation of interleukin-6 responses in ectopic endometrial
stromal cells: Correlation with decreased soluble receptor levels
in peritoneal fluid of women with endometriosis. J Clin Endocrinol
Metab. 80:1431–1437. 1995.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Candido S, Tomasello BMR, Lavoro A,
Falzone L and Gattuso Gand Libra M: Novel insights into epigenetic
regulation of IL6 pathway: In silico perspective on inflammation
and cancer relationship. Int J Mol Sci. 22(10172)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Baran P, Hansen S, Waetzig GH, Akbarzadeh
M, Lamertz L, Huber HJ, Ahmadian MR, Moll JM and Scheller J: The
balance of interleukin (IL)-6, IL-6.soluble IL-6 receptor (sIL-6R),
and IL-6.sIL-6R.sgp130 complexes allows simultaneous classic and
trans-signaling. J Biol Chem. 293:6762–6775. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mihara M, Hashizume M, Yoshida H, Suzuki M
and Shiina M: IL-6/IL-6 receptor system and its role in
physiological and pathological conditions. Clin Sci (Lond).
122:143–159. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Che Q, Xiao X, Liu M, Lu Y, Dong X and Liu
S: IL-6 promotes endometrial cancer cells invasion and migration
through signal transducers and activators of transcription 3
signaling pathway. Pathol Res Pract. 215(152392)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Doyle LM and Wang MZ: Overview of
extracellular vesicles, their origin, composition, purpose, and
methods for exosome isolation and analysis. Cells.
8(727)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li P, Kaslan M, Lee SH, Yao J and Gao Z:
Progress in exosome isolation techniques. Theranostics. 7:789–804.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Andreu Z and Yanez-Mo M: Tetraspanins in
extracellular vesicle formation and function. Front Immunol.
5(442)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Freger S, Leonardi M and Foster WG:
Exosomes and their cargo are important regulators of cell function
in endometriosis. Reprod Biomed Online. 43:370–378. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Khalaj K, Miller JE, Lingegowda H,
Fazleabas AT, Young SL, Lessey BA, Koti M and Tayade C:
Extracellular vesicles from endometriosis patients are
characterized by a unique miRNA-lncRNA signature. JCI Insight.
4(e128846)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jung MK and Mun JY: Sample preparation and
imaging of exosomes by transmission electron microscopy. J Vis Exp.
56482:2018.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Othman N, Jamal R and Abu N:
Cancer-Derived exosomes as effectors of key inflammation-related
players. Front Immunol. 10(2103)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li KL, Huang HY, Ren H and Yang XL: Role
of exosomes in the pathogenesis of inflammation in Parkinson's
disease. Neural Regen Res. 17:1898–1906. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Isola AL and Chen S: Exosomes: The
messengers of health and disease. Curr Neuropharmacol. 15:157–165.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fan Y, Chen Z and Zhang M: Role of
exosomes in the pathogenesis, diagnosis, and treatment of central
nervous system diseases. J Transl Med. 20(291)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Genc S, Pennisi M, Yeni Y, Yildirim S,
Gattuso G, Altinoz MA, Taghizadehghalehjoughi A, Bolat I, Tsatsakis
A, Hacımüftüoğlu A and Falzone L: Potential neurotoxic effects of
glioblastoma-derived exosomes in primary cultures of cerebellar
neurons via oxidant stress and glutathione depletion. Antioxidants
(Basel). 11(1225)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang M, Wang X, Xia X, Fang X, Zhang T
and Huang F: Endometrial epithelial cells-derived exosomes deliver
microRNA-30c to block the BCL9/Wnt/CD44 signaling and inhibit cell
invasion and migration in ovarian endometriosis. Cell Death Discov.
8(151)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Soroczynska K, Zareba L, Dlugolecka M and
Czystowska-Kuzmicz M: Immunosuppressive extracellular vesicles as a
linking factor in the development of tumor and endometriotic
lesions in the gynecologic tract. Cells. 11(1483)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bordonne C, Puntonet J, Maitrot-Mantelet
L, Bourdon M, Marcellin L, Dion E, Plu-Bureau G, Santulli P and
Chapron C: Imaging for evaluation of endometriosis and adenomyosis.
Minerva Obstet Gynecol. 73:290–303. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Maruyama S, Imanaka S, Nagayasu M, Kimura
M and Kobayashi H: Relationship between adenomyosis and
endometriosis; Different phenotypes of a single disease? Eur J
Obstet Gynecol Reprod Biol. 253:191–197. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bilgic E, Guzel E, Kose S, Aydin MC,
Karaismailoglu E, Akar I, Usubutun A and Korkusuz P:
Endocannabinoids modulate apoptosis in endometriosis and
adenomyosis. Acta Histochem. 119:523–532. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang JH, Duan H, Wang S, Wang YY and Lv
CX: Upregulated microRNA let-7a accelerates apoptosis and inhibits
proliferation in uterine junctional zone smooth muscle cells in
adenomyosis under conditions of a normal activated hippo-YAP1 axis.
Reprod Biol Endocrinol. 19(81)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zarmakoupis PN, Rier SE, Maroulis GB and
Becker JL: Inhibition of human endometrial stromal cell
proliferation by interleukin 6. Hum Reprod. 10:2395–2399.
1995.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yoshioka H, Harada T, Iwabe T, Nagano Y,
Taniguchi F, Tanikawa M and Terakawa N: Menstrual cycle-specific
inhibition of the proliferation of endometrial stromal cells by
interleukin 6 and its soluble receptor. Am J Obstet Gynecol.
180:1088–1094. 1999.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang JH, Chen MJ, Wu MY, Chen YC, Yang YS
and Ho HN: Decreased suppression of interleukin-6 after treatment
with medroxyprogesterone acetate and danazol in endometrial stromal
cells of women with adenomyosis. Fertil Steril. 86:1459–1465.
2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yang JH, Wu MY, Chang DY, Chang CH, Yang
YS and Ho HN: Increased interleukin-6 messenger RNA expression in
macrophage-cocultured endometrial stromal cells in adenomyosis. Am
J Reprod Immunol. 55:181–187. 2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhihong N, Yun F, Pinggui Z, Sulian Z and
Zhang A: Cytokine profiling in the eutopic endometrium of
adenomyosis during the implantation window after ovarian
stimulation. Reprod Sci. 23:124–133. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen YJ, Li HY, Chang YL, Yuan CC, Tai LK,
Lu KH, Chang CM and Chiou SH: Suppression of migratory/invasive
ability and induction of apoptosis in adenomyosis-derived
mesenchymal stem cells by cyclooxygenase-2 inhibitors. Fertil
Steril. 94:1972–1979, 1979 e1-4. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ozcelik K, Capar M, Gazi Ucar M, Cakiotar
T, Ozcelik F and Tuyan Ilhan T: Are cytokine levels in serum,
endometrial tissue, and peritoneal fluid a promising predictor to
diagnosis of endometriosis-adenomyosis? Clin Exp Obstet Gynecol.
43:569–572. 2016.PubMed/NCBI
|
|
42
|
Paktinat S, Hashemi SM, Ghaffari Novin M,
Mohammadi-Yeganeh S, Salehpour S, Karamian A and Nazarian H:
Seminal exosomes induce interleukin-6 and interleukin-8 secretion
by human endometrial stromal cells. Eur J Obstet Gynecol Reprod
Biol. 235:71–76. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shi S, Tan Q, Liang J, Cao D, Wang S,
Liang J, Chen K and Wang Z: Placental trophoblast cell-derived
exosomal microRNA-1290 promotes the interaction between endometrium
and embryo by targeting LHX6. Mol Ther Nucleic Acids. 26:760–772.
2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zouzoulas OD, Tsolakidis D, Efstratiou I,
Pervana S, Pazarli E and Grimbizis G: Correlation between
adenomyosis and endometrial cancer: 6-year experience of a single
center. Facts Views Vis Obgyn. 10:147–152. 2018.PubMed/NCBI
|
|
45
|
Yeh CC, Su FH, Tzeng CR, Muo CH and Wang
WC: Women with adenomyosis are at higher risks of endometrial and
thyroid cancers: A population-based historical cohort study. PLoS
One. 13(e0194011)2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Subramaniam KS, Omar IS, Kwong SC, Mohamed
Z, Woo YL, Mat Adenan NA and Chung I: Cancer-associated fibroblasts
promote endometrial cancer growth via activation of
interleukin-6/STAT-3/c-Myc pathway. Am J Cancer Res. 6:200–213.
2016.PubMed/NCBI
|
|
47
|
van der Zee M, Sacchetti A, Cansoy M,
Joosten R, Teeuwssen M, Heijmans-Antonissen C, Ewing-Graham PC,
Burger CW, Blok LJ and Fodde R: IL6/JAK1/STAT3 signaling blockade
in endometrial cancer affects the ALDHhi/CD126+ stem-like component
and reduces tumor Burden. Cancer Res. 75:3608–3622. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Struble J, Reid S and Bedaiwy MA:
Adenomyosis: A clinical review of a challenging gynecologic
condition. J Minim Invasive Gynecol. 23:164–185. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Senturk LM and Imamoglu M: Adenomyosis:
What is new? Womens Health (Lond). 11:717–724. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Abbott JA: Adenomyosis and abnormal
uterine bleeding (AUB-A)-Pathogenesis, diagnosis, and management.
Best Pract Res Clin Obstet Gynaecol. 40:68–81. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Falzone L, Candido S, Docea AO and Calina
D: Editorial: Inflammation and aging in chronic and degenerative
diseases: Current and future therapeutic strategies. Front
Pharmacol. 13(1122786)2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Machlin JH, Barishansky SJ, Kelsh J,
Larmore MJ, Johnson BW, Pritchard MT, Pavone ME and Duncan FE:
Fibroinflammatory signatures increase with age in the human ovary
and follicular fluid. Int J Mol Sci. 22(4902)2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Protopapas A, Grimbizis G, Athanasiou S
and Loutradis D: Adenomyosis: Disease, uterine aging process
leading to symptoms, or both? Facts Views Vis Obgyn. 12:91–104.
2020.PubMed/NCBI
|
|
54
|
Sanchez-Prieto M, Sanchez-Borrego R,
Lubian-Lopez DM and Perez-Lopez FR: Etiopathogenesis of ovarian
cancer. An inflamm-aging entity? Gynecol Oncol Rep.
42(101018)2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Liu Y, Zhang H, Zhang TX, Yuan M, Du C,
Zeng P, Huang Z, Jia D, Yang G, Shi FD and Zhang C: Effects of
tocilizumab therapy on circulating B cells and T helper cells in
patients with neuromyelitis optica spectrum disorder. Front
Immunol. 12(703931)2021.PubMed/NCBI View Article : Google Scholar
|
